Leader in Epidemic Risk Modeling Shares Predictions for Industries Ripe for Epidemic Risk Insurance
SAN FRANCISCO (PRWEB) January 09, 2019
Today, Metabiota, the pioneer in epidemic risk modeling, is unveiling its predictions for the industries that are most likely to be impacted by a health crisis in the year ahead. According to a recent survey by North Carolina State University’s Enterprise Risk Management (ERM) and management consulting firm Protiviti, board members and C-suite executives want to devote additional time or resources to risk management efforts in 2019. Epidemic risk is a very real threat facing today’s companies. In fact, in the last decade, there have been over 400 high priority human disease outbreaks- and those have impacted the stability of economies and corporations everywhere. The Zika virus alone may end up costing Latin America and the Caribbean up to $18 billion, and the South Korean MERS outbreak in 2015 caused a 40 percent drop in tourism, costing the country an estimated loss of $900 million in revenue.
“As we get better at understanding how outbreak events have, and could, play out, we also are getting better at translating that information into business impacts,” said Dr. Patrick Ayscue, director of epidemiology at Metabiota. “Leveraging Metabiota’s unique Pathogen Sentiment Index that can estimate public fear and potential impact of these events to businesses, we’re able to help companies, economies and the world become more resilient to the devastating financial setbacks related to outbreaks. And we are now realizing the full potential of these capabilities and the industries they are ready to protect.”
Metabiota’s research shows that outbreaks like acute flaccid myelitis (a "polio-like" illness), Zika, Avian Influenza and even seasonal influenza are not one-off scenarios but, in fact, illustrate distinct patterns. To that end, infectious diseases can and should be insured so that, like natural disasters, resources, financing and other support can be established to offset the impact. Working in collaboration with MunichRe and Marsh & McLennan, Metabiota is delivering a comprehensive methodology for quantifying the potential impacts of epidemics so that the risk can be understood and policies can be delivered to protect countries and corporations from financial setbacks related to a health crisis.
Because of Metabiota’s purview into the intersection of health events and risk management, the company is revealing its predictions for the industries that are most in danger of business interruption and financial loss, as a result of an epidemic.
For more information on Metabiota and its approach, visit http://www.metabiota.com.
About Metabiota
Metabiota is the pioneer in comprehensive risk analytics that help organizations and countries build resilience to epidemics and protect global public health. Built on a strong foundation of scientific expertise, including a worldwide network of on-the-ground experts, Metabiota delivers actionable, data-driven analytics to help countries and corporations mitigate complex health issues. With a strategic global presence and sustained partnerships, Metabiota’s agile approach helps identify, analyze and transfer the risk associated with biological threats. The company’s international footprint includes operations in nearly 20 countries and offices in San Francisco, Canada, Cameroon and the Democratic Republic of the Congo. For more information, visit http://www.metabiota.com.